The new KeraKlear XT models of the KeraKlear Artificial Cornea can now be implanted at variable depths to treat a wide variety of corneal conditions. Depths range from 200 to 700 microns in 100 micron steps to allow customized treatment of keratoconus, stromal corneal opacities and corneal edema.
The KeraKlear is indicated for patients that have non-inflammatory forms of corneal blindness (e.g. keratoconus, corneal dystrophies, corneal scars, and corneal edema). The KeraKlear should not be used in patients with inflammatory causes of corneal blindness such as Steven’s Johnson Syndrome, ocular cicatricial pemphigoid or atopic keratoconjunctivitis.
Yichieh Shiuey, MD and Jose M. Vargas, MD